Eisai
4523.T
#2213
Rank
$8.30 B
Marketcap
$29.46
Share price
-2.53%
Change (1 day)
2.81%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total debt

Total debt on the balance sheet as of September 2025 : $1.59 Billion USD

According to Eisai's latest financial reports the company's total debt is $1.59 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Eisai - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2025-03-31$1.25 B18.8%
2024-03-31$1.05 B11.34%
2023-03-31$0.94 B21.34%
2022-03-31$0.77 B-3.98%
2021-03-31$0.81 B-2.98%
2020-03-31$0.83 B-33.15%
2019-03-31$1.25 B-23.16%
2018-03-31$1.62 B-15.11%
2017-03-31$1.91 B6%
2016-03-31$1.81 B-7.98%
2015-03-31$1.96 B-17.88%
2014-03-31$2.39 B-28.08%
2013-03-31$3.33 B-20.07%
2012-03-31$4.16 B-8.56%
2011-03-31$4.55 B4.36%
2010-03-31$4.36 B2.16%
2009-03-31$4.27 B5.66%
2008-03-31$4.04 B201756.18%
2007-03-31$2 M-42.84%
2006-03-31$3.5 M-54.74%
2005-03-31$7.74 M320.75%
2004-03-31$1.84 M519.62%
2003-03-31$0.29 M-99.39%
2002-03-31$49.03 M-21.56%
2001-03-31$62.51 M-63.69%
2000-03-31$0.17 B